UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended  SEPTEMBER 30, 2006MARCH 31, 2007

 

Commission file number: 1-1463

 

UNION CARBIDE CORPORATION

(Exact name of registrant as specified in its charter)

 

New York

 

13-1421730

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

 

400 West Sam Houston Parkway South, Houston, Texas

77042

(Address of principal executive offices)               (Zip

(Zip Code)

 

 

 

Registrant’s telephone number, including area code: 713-978-2016

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was

required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

ý Yes

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was  required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.                         ý Yes     o No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer o

Accelerated filer o

Non-accelerated filer ý

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

oYes

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).        o Yes      ý No

 

At September 30, 2006,March 31, 2007, 1,000 shares of common stock were outstanding, all of which were held by the registrant’s parent, The Dow Chemical Company.

 

The registrant meets the conditions set forth in General Instructions H(1)(a) and (b) for Form 10-Q and is therefore filing this form with a reduced disclosure format.

 




Union Carbide Corporation

TABLE OF CONTENTS

 

PAGE

 

PART I - FINANCIAL INFORMATION

 

 

 

 

 

 

 

Item 1. Financial Statements.

 

3

 

 

 

 

 

Consolidated Statements of Income

 

3

 

 

 

 

 

Consolidated Balance Sheets

 

4

 

 

 

 

 

Consolidated Statements of Cash Flows

 

6

 

 

 

 

 

Consolidated Statements of Comprehensive Income

 

6

 

 

 

 

 

Notes to the Consolidated Financial Statements

 

7

 

 

 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

1513

 

 

 

 

 

Disclosure Regarding Forward-Looking Information

 

1513

 

 

 

 

 

Results of Operations

 

1513

 

 

 

 

 

Other Matters

 

1614

 

 

 

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

1917

 

 

 

 

 

Item 4. Controls and Procedures.

 

1917

 

 

 

 

 

PART II - OTHER INFORMATION

 

 

 

 

 

 

 

Item 1. Legal Proceedings.

 

1917

 

 

 

 

 

Item 1A. Risk Factors.

 

1917

 

 

 

 

 

Item 6. Exhibits.

 

1917

 

 

 

 

 

SIGNATURES

 

2018

 

 

 

 

 

EXHIBIT INDEX

 

2119

 

 

2




PART I -I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.STATEMENTS

Union Carbide Corporation and Subsidiaries

Consolidated Statements of Income

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

Sept. 30,

 

Sept. 30,

 

Sept. 30,

 

Sept. 30,

 

In millions (Unaudited)

 

2006

 

2005

 

2006

 

2005

 

Net trade sales

 

$

55

 

$

73

 

$

429

 

$

218

 

Net sales to related companies

 

1,845

 

1,392

 

5,300

 

4,515

 

Total Net Sales

 

1,900

 

1,465

 

5,729

 

4,733

 

Cost of sales

 

1,727

 

1,321

 

4,966

 

4,145

 

Research and development expenses

 

17

 

19

 

57

 

58

 

Selling, general and administrative expenses

 

4

 

4

 

16

 

14

 

Restructuring charges

 

13

 

 

13

 

 

Equity in earnings of nonconsolidated affiliates

 

144

 

105

 

288

 

356

 

Sundry income (expense) - net

 

(16

)

(2

)

(60

)

51

 

Interest income

 

34

 

6

 

92

 

16

 

Interest expense and amortization of debt discount

 

14

 

15

 

40

 

57

 

Income before Income Taxes

 

287

 

215

 

957

 

882

 

Provision for income taxes

 

69

 

31

 

301

 

228

 

Net Income Available for Common Stockholder

 

$

218

 

$

184

 

$

656

 

$

654

 

Depreciation

 

$

67

 

$

66

 

$

206

 

$

201

 

Capital Expenditures

 

$

51

 

$

45

 

$

146

 

$

139

 

 

 

 

Three Months Ended

 

In millions   (Unaudited)

 

March 31,
2007

 

March 31,
2006

 

Net trade sales

 

$

53

 

$

318

 

Net sales to related companies

 

1,673

 

1,735

 

Total Net Sales

 

1,726

 

2,053

 

Cost of sales

 

1,598

 

1,636

 

Research and development expenses

 

20

 

21

 

Selling, general and administrative expenses

 

7

 

11

 

Equity in earnings of nonconsolidated affiliates

 

124

 

61

 

Sundry expense - net

 

(10

)

(21

)

Interest income

 

37

 

23

 

Interest expense and amortization of debt discount

 

15

 

13

 

Income before Income Taxes

 

237

 

435

 

Provision for income taxes

 

51

 

152

 

Net Income Available for Common Stockholder

 

$

186

 

$

283

 

Depreciation

 

$

68

 

$

68

 

Capital Expenditures

 

$

46

 

$

41

 

See Notes to the Consolidated Financial Statements.

3





Union Carbide Corporation and Subsidiaries

Consolidated Balance Sheets

In millions (Unaudited)

 

Sept. 30,
2006

 

Dec. 31,
2005

 

Assets

 

 

 

 

 

Current Assets

 

 

 

 

 

Cash and cash equivalents

 

$

73

 

$

73

 

Accounts receivable:

 

 

 

 

 

Trade (net of allowance for doubtful receivables - 2006: $2; 2005: $3)

 

45

 

53

 

Related companies

 

463

 

508

 

Other

 

78

 

96

 

Notes receivable from related companies

 

2,264

 

1,631

 

Inventories

 

204

 

181

 

Deferred income tax assets - current

 

14

 

58

 

Asbestos-related insurance receivables - current

 

79

 

117

 

Total current assets

 

3,220

 

2,717

 

Investments

 

 

 

 

 

Investments in related companies

 

297

 

287

 

Investments in nonconsolidated affiliates

 

867

 

887

 

Other investments

 

21

 

13

 

Noncurrent receivables

 

59

 

62

 

Noncurrent lreceivable from related company

 

198

 

197

 

Total investments

 

1,442

 

1,446

 

Property

 

 

 

 

 

Property

 

7,438

 

7,415

 

Less accumulated depreciation

 

5,476

 

5,378

 

Net property

 

1,962

 

2,037

 

Other Assets

 

 

 

 

 

Goodwill

 

26

 

26

 

Other intangible assets (net of accumulated amortization - 2006: $123; 2005: $120)

 

24

 

22

 

Asbestos-related insurance receivables - noncurrent

 

750

 

818

 

Prepaid pension expense

 

856

 

806

 

Deferred charges and other assets

 

48

 

62

 

Total other assets

 

1,704

 

1,734

 

Total Assets

 

$

8,328

 

$

7,934

 

In millions   (Unaudited)

 

March 31,
2007

 

Dec. 31,
2006

 

Assets

 

Current Assets

 

 

 

 

 

Cash and cash equivalents

 

$

77

 

$

71

 

Accounts receivable:

 

 

 

 

 

Trade (net of allowance for doubtful receivables - 2007: $8; 2006: $2)

 

26

 

33

 

Related companies

 

373

 

449

 

Other

 

132

 

145

 

Notes receivable from related companies

 

2,867

 

2,547

 

Inventories

 

206

 

199

 

Deferred income tax assets - current

 

67

 

41

 

Total current assets

 

3,748

 

3,485

 

Investments

 

 

 

 

 

Investments in related companies

 

297

 

297

 

Investments in nonconsolidated affiliates

 

799

 

896

 

Other investments

 

20

 

23

 

Noncurrent receivables

 

56

 

58

 

Noncurrent receivable from related company

 

207

 

187

 

Total investments

 

1,379

 

1,461

 

Property

 

 

 

 

 

Property

 

7,470

 

7,459

 

Less accumulated depreciation

 

5,523

 

5,489

 

Net property

 

1,947

 

1,970

 

Other Assets

 

 

 

 

 

Goodwill

 

26

 

26

 

Other intangible assets (net of accumulated amortization - 2007: $124; 2006: $122)

 

24

 

25

 

Deferred income tax assets - noncurrent

 

192

 

115

 

Asbestos-related insurance receivables - noncurrent

 

725

 

725

 

Deferred charges and other assets

 

399

 

383

 

Total other assets

 

1,366

 

1,274

 

Total Assets

 

$

8,440

 

$

8,190

 

See Notes to the Consolidated Financial Statements.

4





Union Carbide Corporation and Subsidiaries

Consolidated Balance Sheets

In millions (Unaudited)

 

Sept. 30,
2006

 

Dec. 31,
2005

 

Liabilities and Stockholder’s Equity

 

 

 

 

 

Current Liabilities

 

 

 

 

 

Notes payable:

 

 

 

 

 

Related companies

 

$

8

 

$

4

 

Other

 

4

 

4

 

Long-term debt due within one year

 

2

 

2

 

Accounts payable:

 

 

 

 

 

Trade

 

230

 

292

 

Related companies

 

249

 

317

 

Other

 

38

 

29

 

Income taxes payable

 

77

 

41

 

Asbestos-related liabilities - current

 

136

 

121

 

Accrued and other current liabilities

 

238

 

235

 

Total current liabilities

 

982

 

1,045

 

Long-Term Debt

 

820

 

822

 

Other Noncurrent Liabilities

 

 

 

 

 

Deferred income taxes payable - noncurrent

 

30

 

89

 

Pension and other postretirement benefits - noncurrent

 

444

 

455

 

Asbestos-related liabilities - noncurrent

 

1,273

 

1,384

 

Other noncurrent obligations

 

347

 

361

 

Total other noncurrent liabilities

 

2,094

 

2,289

 

Minority Interest in Subsidiaries

 

3

 

4

 

Stockholder’s Equity

 

 

 

 

 

Common stock (1,000 shares authorized and issued)

 

 

 

Additional paid-in capital

 

121

 

121

 

Retained earnings

 

4,392

 

3,736

 

Accumulated other comprehensive loss

 

(84

)

(83

)

Net stockholder’s equity

 

4,429

 

3,774

 

Total Liabilities and Stockholder’s Equity

 

$

8,328

 

$

7,934

 

In millions   (Unaudited)

 

March 31,
2007

 

Dec. 31,
2006

 

Liabilities and Stockholder’s Equity

 

Current Liabilities

 

 

 

 

 

Notes payable:

 

 

 

 

 

Related companies

 

$

9

 

$

8

 

Other

 

 

1

 

Accounts payable:

 

 

 

 

 

Trade

 

232

 

292

 

Related companies

 

208

 

252

 

Other

 

30

 

40

 

Income taxes payable

 

205

 

49

 

Asbestos-related liabilities – current

 

133

 

129

 

Pension and other postretirement benefits – current

 

56

 

56

 

Accrued and other current liabilities

 

141

 

116

 

Total current liabilities

 

1,014

 

943

 

Long-Term Debt

 

820

 

820

 

Other Noncurrent Liabilities

 

 

 

 

 

Pension and other postretirement benefits – noncurrent

 

510

 

518

 

Asbestos-related liabilities - noncurrent

 

1,063

 

1,079

 

Other noncurrent obligations

 

488

 

407

 

Total other noncurrent liabilities

 

2,061

 

2,004

 

Minority Interest in Subsidiaries

 

2

 

3

 

Stockholder’s Equity

 

 

 

 

 

Common stock (1,000 shares authorized and issued)

 

 

 

Additional paid-in capital

 

121

 

121

 

Retained earnings (includes cumulative effect of adopting FIN No. 48 of $(67))

 

4,901

 

4,782

 

Accumulated other comprehensive loss

 

(479

)

(483

)

Net stockholder’s equity

 

4,543

 

4,420

 

Total Liabilities and Stockholder’s Equity

 

$

8,440

 

$

8,190

 

See Notes to the Consolidated Financial Statements.

5





Union Carbide Corporation and Subsidiaries

Consolidated Statements of Cash Flows

 

Nine Months Ended

 

 

Three Months Ended

 

In millions (Unaudited)

 

Sept. 30,
2006

 

Sept. 30,
2005

 

 

March 31,
2007

 

March 31,
2006

 

Operating Activities

 

 

 

 

 

 

 

 

 

 

Net Income Available for Common Stockholder

 

$

656

 

$

654

 

 

$

186

 

$

283

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

Adjustments to reconcile net income to net cash provided by

 

 

 

 

 

operating activities:

 

 

 

 

 

Depreciation and amortization

 

227

 

222

 

 

78

 

75

 

Provision (Credit) for deferred income tax

 

(3

)

208

 

Credit for deferred income tax

 

(37

)

(52

)

Earnings of nonconsolidated affiliates less than dividends received

 

4

 

1

 

 

96

 

207

 

Gain on sales of investments, net

 

 

(9

)

Gain on sales of property, net

 

 

(3

)

Other gain, net

 

 

(1

)

Gain on sale of ownership interest in nonconsolidated affiliate

 

 

(70

)

Restructuring charges

 

13

 

 

Changes in assets and liabilities that provided (used) cash:

 

 

 

 

 

Net gain on sales of property

 

(1

)

 

Changes in assets and liabilities:

 

 

 

 

 

Accounts and notes receivable

 

22

 

29

 

 

8

 

13

 

Related company receivables

 

(588

)

(234

)

 

(244

)

(521

)

Inventories

 

(23

)

(21

)

 

(7

)

(58

)

Accounts payable

 

(33

)

(9

)

 

(51

)

(39

)

Related company payables

 

(64

)

(205

)

 

(42

)

(38

)

Other assets and liabilities

 

(59

)

(24

)

 

85

 

165

 

Cash provided by operating activities

 

152

 

538

 

 

71

 

35

 

Investing Activities

 

 

 

 

 

 

 

 

 

 

Capital expenditures

 

(146

)

(139

)

 

(46

)

(41

)

Distributions from nonconsolidated affiliates

 

 

4

 

Change in noncurrent receivable from related company

 

(20

)

1

 

Proceeds from sales of property

 

2

 

7

 

 

3

 

 

Distributions from nonconsolidated affiliates

 

4

 

41

 

Changes in noncurrent receivable from related company

 

(1

)

13

 

Purchases of investments

 

(11

)

(1

)

 

(1

)

(1

)

Proceeds from sales of investments

 

3

 

 

Cash used in investing activities

 

(149

)

(79

)

 

(64

)

(37

)

Financing Activities

 

 

 

 

 

 

 

 

 

 

Changes in short-term notes payable

 

(1

)

(1

)

 

(1

)

(1

)

Payments on long-term debt

 

(2

)

(436

)

 

 

(2

)

Cash used in financing activities

 

(3

)

(437

)

 

(1

)

(3

)

Summary

 

 

 

 

 

 

 

 

 

 

Increase in cash and cash equivalents

 

 

22

 

Increase (Decrease) in cash and cash equivalents

 

6

 

(5

)

Cash and cash equivalents at beginning of year

 

73

 

22

 

 

71

 

73

 

Cash and cash equivalents at end of period

 

$

73

 

$

44

 

 

$

77

 

$

68

 

See Notes to the Consolidated Financial Statements.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Union Carbide Corporation and Subsidiaries

Union Carbide Corporation and Subsidiaries

 

Consolidated Statements of Comprehensive Income

Consolidated Statements of Comprehensive Income

 

 

Three Months Ended

 

In millions (Unaudited)

 

March 31,
2007

 

March 31,
2006

 

Net Income Available for Common Stockholder

 

$

186

 

$

283

 

Other Comprehensive Income (Loss), Net of Tax

 

 

 

 

 

Unrealized loss on investments

 

 

(1

)

Pension and other postretirement benefit plans adjustment

 

4

 

 

Net gain on cash flow hedging derivative instruments

 

 

1

 

Total other comprehensive income

 

4

 

 

Comprehensive Income

 

$

190

 

$

283

 

See Notes to the Consolidated Financial Statements.

 

 

 

 

 

 

See Notes to the Consolidated Financial Statements.

Union Carbide Corporation and Subsidiaries

Consolidated Statements of Comprehensive Income

 

 

Three Months Ended

 

Nine Months Ended

 

In millions (Unaudited)

 

Sept. 30,
2006

 

Sept. 30,
2005

 

Sept. 30,
2006

 

Sept. 30,
2005

 

Net Income Available for Common Stockholder

 

$

218

 

$

184

 

$

656

 

$

654

 

Other Comprehensive Income (Loss), Net of Tax

 

 

 

 

 

 

 

 

 

Translation adjustments

 

(1

)

(2

)

 

(12

)

Minimum pension liability adjustment

 

 

 

 

6

 

Net gain (loss) on cash flow hedging derivative instruments

 

(2

)

1

 

(1

)

1

 

Total other comprehensive loss

 

(3

)

(1

)

(1

)

(5

)

Comprehensive Income

 

$

215

 

$

183

 

$

655

 

$

649

 

See Notes to the Consolidated Financial Statements.

6




Union Carbide Corporation and Subsidiaries

Notes to the Consolidated Financial Statements

(Unaudited)

NOTE A     CONSOLIDATED FINANCIAL STATEMENTS

The unaudited interim consolidated financial statements of Union Carbide Corporation and its subsidiaries (the “Corporation” or “UCC”) were prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and reflect all adjustments (including normal recurring accruals) which, in the opinion of management, are considered necessary for the fair presentation of the results for the periods presented.

The Corporation is a wholly owned subsidiary of The Dow Chemical Company (“Dow”). In accordance with Statement of Financial Accounting Standards (“SFAS”) No. 128, “Earnings Per Share,” the presentation of earnings per share is not required in financial statements of wholly owned subsidiaries.

The Corporation’s business activities comprise components of Dow’s global operations rather than stand-alone operations. Dow conducts its worldwide operations through global businesses. Because there are no separable reportable business segments for UCC under SFAS No. 131, “Disclosures about Segments of an Enterprise and Related Information,” and no detailed business information is provided to a chief operating decision maker regarding the Corporation’s stand-alone operations, the Corporation’s results are reported as a single operating segment.

Intercompany transactions and balances are eliminated in consolidation. Transactions with the Corporation’s parent company, Dow, or other Dow subsidiaries have been reflected as related company transactions in the consolidated financial statements. See Note G for further discussion.

Certain reclassifications of prior year’s amounts have been made to conform to the presentation adopted for 2007. These statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Corporation’s Annual Report on Form 10-K for the year ended December 31, 2005.2006.

NOTE B     RECENT ACCOUNTING CHANGES

Accounting for Conditional Asset Retirement ObligationsPRONOUNCEMENTS

In March 2005,June 2006, the Financial Accounting Standards Board (“FASB”) issued FASB Interpretation (“FIN”) No. 47, “Accounting for Conditional Asset Retirement Obligations,” which clarifies the term conditional asset retirement obligation as used in SFAS No. 143, “Accounting for Asset Retirement Obligations,” as a legal obligation to perform an asset retirement activity in which the timing and/or method of settlement are conditional on a future event that may or may not be within the control of the Corporation. FIN No. 47 was effective no later than the end of fiscal years ending after December 15, 2005.

The Corporation has 17 manufacturing sites in six countries. Most of these sites contain numerous individual manufacturing operations, particularly at the Corporation’s larger sites. Asset retirement obligations are recorded in the period in which they are incurred and reasonably estimable, including those obligations for which the timing and/or method of settlement are conditional on a future event that may or may not be within the control of the Corporation. Retirement of assets may involve such efforts as remediation and treatment of asbestos, contractually required demolition, and other related activities, depending on the nature and location of the assets, and are typically realized only upon demolition of those facilities. In identifying asset retirement obligations, the Corporation considers identification of legally enforceable obligations, changes in existing law, estimates of potential settlement dates and the calculation of an appropriate discount rate to be used in calculating the fair value of the obligations. The Corporation has a well-established global process to identify, approve and track the demolition of retired or to-be-retired facilities; no assets are retired from service until this process has been followed. The Corporation typically forecasts demolition projects based on the usefulness of the assets; environmental, health and safety concerns; and other similar considerations. Under this process, as demolition projects are identified and approved, reasonable estimates may then be determined for the time frames during which any related asset retirement obligations are expected to be settled. For those assets where a range of potential settlement dates may be reasonably estimated, obligations are recorded.

Assets that have not been submitted/reviewed for potential demolition activities are considered to have continued usefulness and are generally still operating “normally.” Therefore, without a plan to demolish the assets or the expectation of a plan, such as shortening the useful life of assets for depreciation purposes under the requirements of SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets,” the Corporation is unable to reasonably forecast a time frame to use for present value calculations. As such, the Corporation has not recognized obligations for individual plants/buildings at its 17 manufacturing sites where estimates of potential settlement dates cannot be reasonably made. The Corporation routinely reviews all changes to the list of items under consideration for demolition to determine if an adjustment to the value of the asset retirement obligation is required.

Adoption of FIN No. 47 on December 31, 2005 resulted in the recognition of an asset retirement obligation of $12 million and a charge of $8 million (net of tax of $4 million), which was included in “Cumulative effect of changes in accounting principles” in the fourth quarter of 2005. The discount rate used to calculate the Corporation’s asset retirement obligations was 4.6 percent.

7




If the conditional asset retirement obligation measurement and recognition provisions of FIN No. 47 had been in effect on January 1, 2005, the aggregate carrying amount of those obligations on that date would have been $12 million. If the amortization of asset retirement cost and accretion of asset retirement obligation provisions of FIN No. 47 had been in effect during 2005, the impact on “Net Income Available to Common Stockholder” would have been immaterial.

In accordance with FIN No. 47, the Corporation has recognized conditional asset retirement obligations related to asbestos encapsulation as a result of planned demolition and remediation activities at manufacturing and administrative sites in the United States. At December 31, 2005, the aggregate carrying amount of conditional asset retirement obligations recognized by the Corporation was $12 million. The aggregate carrying amount of conditional asset retirement obligations was $13 million at September 30, 2006. These obligations are included in the consolidated balance sheets as “Other noncurrent obligations.”

As described above, the Corporation has not recognized conditional asset retirement obligations for which a fair value cannot be reasonably estimated in its consolidated financial statements. It is the opinion of management that the possibility is remote that such conditional asset retirement obligations, when estimable, will have a material adverse impact on the Corporation’s consolidated financial statements based on current costs.

Other Accounting Changes

In November 2004, the FASB issued SFAS No. 151, “Inventory Costs — an amendment of ARB No. 43, Chapter 4,” which clarifies the accounting for abnormal amounts of idle facility expense, freight, handling costs, and wasted material (spoilage) and also requires that the allocation of fixed production overhead be based on the normal capacity of the production facilities. SFAS No. 151 was effective for inventory costs incurred during fiscal years beginning after June 15, 2005. Because the Corporation previously used nameplate capacity to calculate product costs, adoption of SFAS No. 151 on January 1, 2006 had an immaterial favorable impact on the Corporation’s consolidated financial statements.

On January 1, 2006, Dow adopted revised SFAS No. 123 (“SFAS No. 123R”), “Share-Based Payment.” The Corporation will continue to be allocated the portion of expense relating to its employees who receive stock-based compensation, which was immaterial in the first nine months of 2006.

In September 2005, the FASB ratified the consensus reached by the Emerging Issues Task Force (“EITF”) with respect to EITF Issue No. 04-13, “Accounting for Purchases and Sales of Inventory with the Same Counterparty.” EITF Issue No. 04-13 is effective for new arrangements entered into, and modifications or renewals of existing arrangements, in the first interim or annual period beginning after March 15, 2006. The Corporation has determined that its current accounting treatment for purchases and sales of inventory with the same counterparty is consistent with the guidance in EITF Issue No. 04-13; therefore, the issue had no impact on the Corporation’s consolidated financial statements.

In June 2006, the FASB issued FIN No. 48, “Accounting for Uncertainty in Income Taxes,” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements in accordance with SFAS No. 109, “Accounting for Income Taxes.”109. This interpretation prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This interpretation also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. FIN No. 48 iswas effective for fiscal years beginning after December 15, 2006.

On January 1, 2007, the Corporation adopted the provisions of FIN No. 48. The cumulative effect of adoption was a $67 million reduction of retained earnings. At January 1, 2007, the total amount of unrecognized tax benefits was $251 million, of which $217 million would impact the effective tax rate, if recognized. Interest and penalties associated with uncertain tax positions are recognized as components of the “Provision for income taxes.” The Corporation’s accrual for interest and penalties was $36 million upon adoption of FIN No. 48.

The Corporation is included in Dow’s consolidated federal income tax group and consolidated tax return,return. For Dow, the tax years 1998-2003 are currently under audit by the U.S. Internal Revenue Service and Dowthe review of these years is currently evaluatingexpected to be completed during 2007. It is reasonably possible that a reduction in the unrecognized tax benefits may occur (which may impact UCC’s unrecognized tax benefits); however, quantification of adoptingan estimated range cannot be made at this interpretation.time.

While the Corporation is subject to taxation in certain foreign jurisdictions, its major tax jurisdictions are in the United States. The tax years that remain subject to examination in the United States are 1998 through 2006 for federal income taxes and 2002 through 2006 for state and local income taxes.

In September 2006, the SECFASB issued StaffSFAS No. 158, “Employers’ Accounting Bulletin (“SAB”)for Defined Benefit Pension and Other Postretirement Plans - an amendment of FASB Statements No. 108,87, 88, 106, and 132(R).” This Statement, which expresses the views of the SEC staff regarding the process of quantifying financial statement misstatements. SAB No. 108 provides guidance on the consideration of the effects of prior year misstatements in quantifying current year misstatements for the purpose of a materiality assessment. The guidance of this SAB iswas effective for annual financial statements covering the first fiscal year ending after November 15, 2006, which is December 31, 2006 for the Corporation.  The Corporation, is currently evaluatingrequired employers to recognize the impactfunded status of applying this guidance.defined benefit postretirement plans as an asset or liability on the balance sheet and to recognize changes in that funded status through comprehensive income. See Note F for the Corporation’s disclosures related to pension and other postretirement benefits.

SAB No. 74 Disclosures for Accounting Standards Issued But Not Yet Adopted

In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements,” which defines fair value, establishes a framework for measuring fair value in GAAP, and expands disclosures about fair value measurements. This Statement applies under other accounting pronouncements that require or permit fair value measurements and is effective for fiscal years beginning after November 15, 2007. The Corporation is currently evaluating the impact of adopting this Statement.

In September 2006,February 2007, the FASB issued SFAS No. 158, “Employers’ Accounting159, “The Fair Value Option for Defined Benefit PensionFinancial Assets and Other Postretirement PlansFinancial Liabilities - Including an amendment of FASB StatementsStatement No. 87, 88, 106,115,” which permits entities to choose to measure many financial instruments and 132(R).” This Statement, whichcertain other items at fair value. SFAS No. 159 is effective December 31, 2006 for the Corporation, requires employers to recognize the funded status of defined benefit postretirement plans as an asset or liability on the balance sheet and to recognize changes in that funded status through comprehensive income. SFAS No. 158 also establishes the measurement date of plan assets and obligations as the date of the employer’s

8




beginning of an entity’s first fiscal year end, and provides for additional annual disclosures. UCC currently uses a December 31 measurement date for all of its plans, consistent with its fiscal year end.


that begins after November 15, 2007. The Corporation is currently evaluating if it will elect the impactfair value option for any of adopting this Statement.its eligible financial instruments and other items.

NOTE C     INVENTORIES

The following table provides a breakdown of inventories:

Inventories

In millions

 

Sept. 30,
2006

 

Dec. 31,
2005

 

Inventories
In millions

 

March 31,
2007

 

Dec. 31,
2006

 

Finished goods

 

$

34

 

$

30

 

 

$

30

 

$

35

 

Work in process

 

40

 

26

 

 

45

 

40

 

Raw materials

 

45

 

41

 

 

45

 

37

 

Supplies

 

85

 

84

 

 

86

 

87

 

Total inventories

 

$

204

 

$

181

 

 

$

206

 

$

199

 

 

The reserves reducing inventories from the first-in, first-out (“FIFO”) basis to the last-in, first-out (“LIFO”) basis amounted to $172$142 million at September 30, 2006March 31, 2007 and $164$160 million at December 31, 2005.2006.

NOTE D   OTHER INTANGIBLE ASSETS

The following table provides information regarding the Corporation’s other intangible assets:

Other Intangible Assets

 

At September 30, 2006

 

At December 31, 2005

 

 

At March 31, 2007

 

At December 31, 2006

 

In millions

 

Gross
Carrying
Amount

 

Accumulated
Amortization

 

Net

 

Gross
Carrying
Amount

 

Accumulated
Amortization

 

Net

 

 

Gross
Carrying
Amount

 

Accumulated
Amortization

 

Net

 

Gross
Carrying
Amount

 

Accumulated
Amortization

 

Net

 

Intangible assets with finite lives:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Licenses and intellectual property

 

$

33

 

$

(32

)

$

1

 

$

33

 

$

(32

)

$

1

 

 

$

33

 

$

(32

)

$

1

 

$

33

 

$

(32

)

$

1

 

Patents

 

3

 

(2

)

1

 

4

 

(2

)

2

 

 

3

 

(2

)

1

 

3

 

(2

)

1

 

Software

 

110

 

(88

)

22

 

104

 

(85

)

19

 

 

112

 

(90

)

22

 

111

 

(88

)

23

 

Other

 

1

 

(1

)

 

1

 

(1

)

 

Total

 

$

147

 

$

(123

)

$

24

 

$

142

 

$

(120

)

$

22

 

 

$

148

 

$

(124

)

$

24

 

$

147

 

$

(122

)

$

25

 

 

Amortization expense for software, which is included in “Cost of sales,” was $1 million in the first quarter of 2007 and the first quarter of 2006. Amortization expense for other intangible assets (not including software) was immaterial in the first quarter of 2007 and the first quarter of 2006. Total estimated amortization expense for 20062007 and the next five fiscal years is as follows:

Estimated Amortization Expense
for Next Five Years

In millions

 

 

 

In millions

 

2006

 

$

4

 

2007

 

$

4

 

 

$

5

 

2008

 

$

4

 

 

$

5

 

2009

 

$

4

 

 

$

5

 

2010

 

$

4

 

 

$

5

 

2011

 

$

4

 

 

$

3

 

2012

 

 

 


NOTE E     COMMITMENTS AND CONTINGENT LIABILITIES

Environmental Matters

Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated, based on current law and existing technologies. The Corporation had accrued obligations of $87 million at DecemberAt March 31, 2005 for environmental remediation and restoration costs, including $34 million for the remediation of Superfund sites. At September 30, 2006,2007, the Corporation had accrued obligations of $74$81 million for environmental remediation and restoration costs, including $24$28 million for the remediation of Superfund sites. This is

9




management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the Corporation has accrued liabilities, although the ultimate cost with respect to these particular matters could range up to twice that amount. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmentalregulations and legal standards regarding liability, and evolving technologies for handling site remediation and restoration. At December 31, 2006, the Corporation had accrued obligations of $77 million for environmental remediation and restoration costs, including $25 million for the remediation of Superfund sites. It is the opinion of the Corporation’s management that the possibility is remote that costs in excess of those disclosed will have a material adverse impact on the Corporation’s consolidated financial statements.

Litigation

The Corporation and its subsidiaries are involved in a number of legal proceedings and claims with both private and governmental parties. These cover a wide range of matters, including, but not limited to: product liability; trade regulation; governmental regulatory proceedings; health, safety and environmental matters; employment; patents; contracts; taxes; and commercial disputes.

Separately, the Corporation is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past three decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that UCC sold in the past, alleged exposure to asbestos-containing products located on UCC’s premises, and UCC’s responsibility for asbestos suits filed against a former subsidiary, Amchem Products, Inc. (“Amchem”). In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to the Corporation’s products.

Influenced by the bankruptcy filings of numerous defendants in asbestos-related litigation and the prospects of various forms of state and national legislative reform, the rate at which plaintiffs filed asbestos-related suits against various companies, including the Corporation and Amchem, increased in 2001, 2002 and the first half of 2003. Since then, the rate of filing has significantly abated. The Corporation expects more asbestos-related suits to be filed against it and Amchem in the future, and will aggressively defend or reasonably resolve, as appropriate, both pending and future claims.

Based on a study completed by Analysis, Research & Planning Corporation (“ARPC”) in January 2003, the Corporation increased its December 31, 2002 asbestos-related liability for pending and future claims for the 15-year period ending in 2017 to $2.2 billion, excluding future defense and processing costs. At each balance sheet date,Since then, the Corporation compareshas compared current asbestos claim and resolution activity to the assumptions inresults of the most recent ARPC study at each balance sheet date to determine whether the accrual continues to be appropriate.

In November 2004, the Corporation requested ARPC to review the Corporation’s historical asbestos claim and resolution activity and determine the appropriateness of updating its January 2003 study. In response to that request, ARPC reviewed and analyzed data through November 14, 2004, and again concluded that it was not possible to estimate the full range of the cost of resolving future asbestos-related claims against UCC and Amchem because of various uncertainties associated with the litigation of those claims. ARPC did advise, however, that it was reasonable and feasible to construct a new estimate of the cost of resolving current and future asbestos-related claims using the same two widely used forecasting methodologies used by ARPC in its January 2003 study, if certain assumptions were made. As a result, the following assumptions were made and then used by ARPC:

·                  The number of future claims to be filed annually against UCC and Amchem is unlikely to exceed the level of claims experienced during 2004.

·                  The number of claims filed against UCC and Amchem annually from 2001 to 2003 is considered anomalous for the purpose of estimating future filings.

·                  The number of future claims to be filed against UCC and Amchem will decline at a fairly constant rate each year from 2005.

·                  The average resolution value for pending and future claims will be equivalent to those experienced during 2003 and 2004 (excluding settlements from closed claims filed in Madison County, Illinois with respect to future claims, as changes in the judicial environment in Madison County caused the historical experience of claims in that jurisdiction to not be predictive of results for future claims).

The resulting study completed by ARPC in January 2005, stated thatARPC provided the undiscounted costCorporation with a report summarizing the results of resolving pending and future asbestos-related claims against UCC and Amchem, excluding future defense and processing costs, through 2017 was estimated to be between approximately $1.5 billion and $2.0 billion, depending on which of two accepted methodologies was used.its study. At December 31, 2004, the recorded asbestos-related liability for pending and future claims was $1.6 billion. Based on the low end of the range in the January 2005 study, the recorded asbestos-related liability for pending and future claims at December 31, 2004 would be sufficient to resolve asbestos-related claims against UCC and Amchem into 2019. As in its January 2003 study, ARPC provideddid provide estimates for a longer period of time in its January 2005 study, but also reaffirmed its

10




prior advice that forecasts for shorter periods of time are more accurate than those for longer periods of time. Based on ARPC’s studies, the Corporation’s asbestos litigation experience, and the uncertainties surrounding asbestos litigation and legislative reform efforts, management determined that no change to the accrual was required at December 31, 2004.

In November 2005, the Corporation requested ARPC to review the Corporation’s 2005 asbestos claim and resolution activity and determine the appropriateness of updating theits January 2005 study. In response to that request, ARPC reviewed and analyzed data through October 31, 2005. In January 2006, ARPC stated that an update of theits study would not provide a more likely estimate of future events than the estimate reflected in its study of the previous year and, therefore, the estimate in that study remained applicable.

Based on the Corporation’s own review of the asbestos claim and resolution activity and ARPC’s response, the Corporation determined that no change to the accrual was required atrequired. At December 31, 2005. The2005, the recorded asbestos-related liability for pending and future claims was $1.5 billion.

In November 2006, the Corporation requested ARPC to review the Corporation’s historical asbestos claim and resolution activity and determine the appropriateness of updating its January 2005 study. In response to that request, ARPC reviewed and analyzed data through October 31, 2006 and concluded that the experience from 2004 through 2006 was sufficient for the purpose of forecasting future filings and values of asbestos claims filed against UCC and Amchem, and could be used in


place of previous assumptions to update its January 2005 study. The resulting study, completed by ARPC in December 2006, stated that the undiscounted cost of resolving pending and future asbestos-related claims against UCC and Amchem, excluding future defense and processing costs, through 2021 was estimated to be between approximately $1.2 billion and $1.5 billion. As in its January 2005 study, ARPC provided estimates for a longer period of time in its December 2006 study, but also reaffirmed its prior advice that forecasts for shorter periods of time are more accurate than those for longer periods of time.

Based on ARPC’s December 2006 study and the Corporation’s own review of the asbestos claim and resolution activity, the Corporation decreased its asbestos-related liability for pending and future claims to $1.2 billion at December 31, 2005. Approximately 392006 which covers the 15-year period ending in 2021 (excluding future defense and processing costs). The reduction was $177 million and was shown as “Asbestos-related credit” in the consolidated statements of income for 2006. At December 31, 2006, approximately 25 percent of the recorded liability related to pending claims and approximately 6175 percent related to future claims.

Based on the Corporation’s review of 20062007 activity, the Corporation determined that no changeadjustment to the accrual was required at September 30, 2006.March 31, 2007. The asbestos-related liability for pending and future claims was $1.4$1.2 billion at September 30, 2006.March 31, 2007. Approximately 3528 percent of the recorded liability related to pending claims and approximately 6572 percent related to future claims.

At December 31, 2002, the Corporation increased the receivable for insurance recoveries related to its asbestos liability to $1.35 billion, substantially exhausting its asbestos product liability coverage. The insurance receivable related to the asbestos liability was determined after a thorough review of applicable insurance policies and the 1985 Wellington Agreement, to which the Corporation and many of its liability insurers are signatory parties, as well as other insurance settlements, with due consideration given to applicable deductibles, retentions and policy limits, and taking into account the solvency and historical payment experience of various insurance carriers. The Wellington Agreement and other agreements with insurers are designed to facilitate an orderly resolution and collection of the Corporation’s insurance policies and to resolve issues that the insurance carriers may raise.

The Corporation’s receivable for insurance recoveries related to its asbestos liability was $478 million at September 30, 2006 and $535 million at December 31, 2005. At September 30, 2006, $477 million ($398 million at December 31, 2005) of the receivable for insurance recoveries was related to insurers that are not signatories to the Wellington Agreement and/or do not otherwise have agreements in place regarding their asbestos-related insurance coverage.

In addition, the Corporation had receivables for defense and resolution costs submitted to insurance carriers for reimbursement as follows:

Receivables for Costs Submitted to Insurance Carriers

In millions

 

September 30,
2006

 

December 31,
2005

 

Receivables for defense costs

 

$

9

 

$

73

 

Receivables for resolution costs

 

342

 

327

 

Total

 

$

351

 

$

400

 

The Corporation expenses defense costs as incurred. The pretax impact for defense and resolution costs, net of insurance, was $1 million in the third quarter of 2006 ($24 million in the third quarter of 2005), and $29 million in the first nine months of 2006 ($56 million in the first nine months of 2005), and was reflected in “Cost of sales.”

In September 2003, the Corporation filed a comprehensive insurance coverage case, now proceeding in the Supreme Court of the State of New York, County of New York, seeking to confirm its rights to insurance for various asbestos claims and to facilitate an orderly and timely collection of insurance proceeds. Although the Corporation already has settlements in place concerning coverage for asbestos claims with many of its insurers, including those covered by the 1985 Wellington Agreement, thisThis lawsuit was filed against insurers that are not signatories to the Wellington Agreement and/or do not otherwise have agreements in place with the Corporation regarding their asbestos-related insurance coverage, in order to facilitate an orderly resolution and collection of such insurance policies and to resolve issues that the insurance carriers may raise. The insurance carriers are contesting this litigation. ThroughAlthough the thirdlawsuit is continuing, through the end of the first quarter of 2006,2007, the Corporation had reached settlements with several of the carriers involved in this litigation.

The Corporation’s receivable for insurance recoveries related to its asbestos liability was $484 million at March 31, 2007 and $495 million at December 31, 2006. At March 31, 2007 and December 31, 2006, all of the receivable for insurance recoveries was related to insurers that are not signatories to the Wellington Agreement and/or do not otherwise have agreements in place regarding their asbestos-related insurance coverage.

In addition to the receivable for insurance recoveries related to its asbestos liability, the Corporation had receivables for defense and resolution costs submitted to insurance carriers for reimbursement as follows:

Receivables for Costs Submitted to Insurance Carriers

In millions

 

March 31,
2007

 

Dec. 31,
2006

 

Receivables for defense costs

 

$

35

 

$

34

 

Receivables for resolution costs

 

265

 

266

 

Total

 

$

300

 

$

300

 

The Corporation expenses defense costs as incurred. The pretax impact for defense and resolution costs, net of insurance, was $17 million in the first quarter of 2007 and $14 million in the first quarter of 2006, and was reflected in “Cost of sales.”

After a further review of its insurance policies, with due consideration given to applicable deductibles, retentions and policy limits, after taking into account the solvency and historical payment experience of various insurance carriers; existing insurance settlements; and the advice of outside counsel with respect to the applicable insurance coverage law relating to the terms and conditions of its insurance policies, the

11




Corporation continues to believe that its recorded receivable for insurance recoveries from all insurance carriers is probable of collection.

The amounts recorded for the asbestos-related liability and related insurance receivable described above were based upon current, known facts. However, future events, such as the number of new claims to be filed and/or received each year, the average cost of disposing of each such claim, coverage issues among insurers, and the continuing solvency of various


insurance companies, as well as the numerous uncertainties surrounding asbestos litigation in the United States, could cause the actual costs and insurance recoveries to be higher or lower than those projected or those recorded.

Because of the uncertainties described above, management cannot estimate the full range of the cost of resolving pending and future asbestos-related claims facing the Corporation and Amchem. Management believes that it is reasonably possible that the cost of disposing of the Corporation’s asbestos-related claims, including future defense costs, could have a material adverse impact on the results of operations and cash flows for a particular period and on the consolidated financial position of the Corporation.

While it is not possible at this time to determine with certainty the ultimate outcome of any of the legal proceedings and claims referred to in this filing, management believes that adequate provisions have been made for probable losses with respect to pending claims and proceedings, and that, except for the asbestos-related matters described above, the ultimate outcome of all known and future claims, after provisions for insurance, will not have a material adverse impact on the results of operations, cash flows and consolidated financial position of the Corporation. Should any losses be sustained in connection with any of such legal proceedings and claims in excess of provisions provided and available insurance, they will be charged to income when determinable.

Purchase Commitments

At December 31, 2005,2006, the Corporation had various outstanding commitments for take or pay agreements, with terms extending from one to fiveten years. Such commitments were not in excess of current market prices. The Corporation had an agreement for the purchase of ethylene-related products in Canada; the Corporation assigned its rights and obligations under this purchase agreement to a wholly owned subsidiary of Dow in December 2003. Total purchases under the ethylene-related agreement were $93 million in 2003.

The fixed and determinable portion of obligations under purchase commitments at December 31, 20052006 is presented in the following table:

Fixed and Determinable Portion of Take
or Pay Obligations
at December 31, 20052006

In millions

 

 

 

In millions

 

2006

 

$

10

 

2007

 

10

 

 

$

14

 

2008

 

8

 

 

8

 

2009

 

8

 

 

8

 

2010

 

5

 

 

7

 

2011

 

1

 

2012 and beyond

 

6

 

Total

 

$

41

 

 

$

44

 

 

Guarantees

The Corporation has undertaken obligations to guarantee the performance of certain nonconsolidated affiliates (including the OPTIMAL Group and Nippon Unicar Company Limited) and a former subsidiary of the Corporation (via delivery of cash or other assets) if specified triggering events occur. Non-performance under a contract for commercial and/or financial obligations by the guaranteed party would trigger the obligation of the Corporation to make payments to the beneficiary of the guarantees. Financial obligations include debt and lease arrangements.

The following table provides a summary of the final expiration, maximum future payments, and recorded liability reflected in the consolidated balance sheets for these guarantees.

Guarantees

In millions

 

Final
Expiration

 

Maximum Future
Payments

 

Recorded
Liability

 

Guarantees at September 30, 2006

 

2014

 

$

83

 

$

1

 

Guarantees at December 31, 2005

 

2014

 

$

92

 

$

2

 

In millions

 

Final
Expiration

 

Maximum Future
Payments

 

Recorded
Liability

 

Guarantees at March 31, 2007

 

2014

 

$

84

 

$

1

 

Guarantees at December 31, 2006

 

2014

 

$

84

 

$

1

 

 

12Conditional Asset Retirement Obligations

In accordance with FIN No. 47, the Corporation has recognized conditional asset retirement obligations related to asbestos encapsulation as a result of planned demolition and remediation activities at manufacturing and administrative sites in the United States. The aggregate carrying amount of conditional asset retirement obligations was $13 million at March 31, 2007 and December 31, 2006. The discount rate used to calculate the Corporation’s asset retirement obligations was 4.6 percent. These obligations are included in the consolidated balance sheets as “Accrued and other current liabilities.”

The Corporation has not recognized conditional asset retirement obligations for which a fair value cannot be reasonably estimated in its consolidated financial statements. It is the opinion of management that the possibility is remote that such conditional asset retirement obligations, when estimable, will have a material adverse impact on the Corporation’s consolidated financial statements based on current costs.




NOTE F     PENSION AND OTHER POSTRETIREMENT BENEFITS

Net Periodic Benefit Cost (Credit) for All Significant Plans

 

 

 

Three Months Ended

 

Nine Months Ended

 

In millions

 

September 30,
2006

 

September 30,
2005

 

September 30,
2006

 

September 30,
2005

 

Defined Benefit Pension Plans:

 

 

 

 

 

 

 

 

 

Service cost

 

$

6

 

$

7

 

$

18

 

$

20

 

Interest cost

 

53

 

54

 

159

 

163

 

Expected return on plan assets

 

(83

)

(85

)

(249

)

(256

)

Amortization of prior service cost

 

1

 

 

1

 

1

 

Amortization of net loss

 

7

 

1

 

23

 

2

 

Net periodic benefit credit

 

$

(16

)

$

(23

)

$

(48

)

$

(70

)

 

 

 

 

 

 

 

 

 

 

Other Postretirement Benefits:

 

 

 

 

 

 

 

 

 

Service cost

 

$

1

 

$

1

 

$

3

 

$

3

 

Interest cost

 

8

 

9

 

24

 

26

 

Amortization of prior service credit

 

(1

)

 

(3

)

(1

)

Amortization of net loss

 

1

 

1

 

3

 

4

 

Net periodic benefit cost

 

$

9

 

$

11

 

$

27

 

$

32

 

 

 

Defined Benefit Pension Plans

 

Other Postretirement Benefits

 

 

 

Three Months Ended

 

Three Months Ended

 

In millions

 

March 31,
2007

 

March 31,
2006

 

March 31,
2007

 

March 31,
2006

 

Service cost

 

$

5

 

$

6

 

$

1

 

$

1

 

Interest cost

 

53

 

53

 

7

 

8

 

Expected return on plan assets

 

(79

)

(83

)

 

 

Amortization of prior service cost (credit)

 

1

 

 

(1

)

(1

)

Amortization of net loss

 

7

 

8

 

1

 

1

 

Net periodic benefit cost (credit)

 

$

(13

)

$

(16

)

$

8

 

$

9

 

Employer Contributions

Pension Plans

The Corporation has a defined benefit pension plan that covers substantially all employees in the United States. Benefits are based on length of service and the employee’s three highest consecutive years of compensation.

The Corporation’s funding policy is to contribute to the plans when pension laws and economics either require or encourage funding. As previously disclosed in the Corporation’s Annual Report on Form 10-K for the year ended December 31, 2005, UCC does not expect to contribute assets to its qualified pension plan in 2006. Consistent with that expectation, no contributions were made in the first nine months of 2006. The Corporation also has a non-qualified supplemental pension plan. Benefit payments to retirees under this plan are expected to be $3 million in 2006. In the first nine months of 2006, benefit payments of $2 million were made.

Other Postretirement Benefits

The Corporation provides certain health care and life insurance benefits to retired U.S. employees. The plan provides health care benefits, including hospital, physicians’ services, drug and major medical expense coverage, and life insurance benefits. The Corporation and the retiree share the cost of these benefits, with the Corporation portion increasing as the retiree has increased years of credited service. There is a cap on the Corporation portion. The Corporation has the ability to change these benefits at any time.

The Corporation funds most of the cost of these health care and life insurance benefits as incurred. As previously disclosed in the Corporation’s Annual Report on Form 10-K for the year ended December 31, 2005, UCC does not expect to contribute assets to its other postretirement benefit plans in 2006. Consistent with that expectation, no contributions were made in the first nine months of 2006. Benefit payments to retirees under these plans are expected to be $60 million in 2006. In the first nine months of 2006, benefit payments of $37 million were made.

NOTE G     RELATED PARTY TRANSACTIONS

The Corporation sells products to Dow to simplify the customer interface process. Products are sold to and purchased from Dow at market-based prices in accordance with the terms of Dow’s long-standing intercompany pricing policies. The application of these policies results in products being sold to and purchased from Dow at market-based prices. The Corporation also procures certain commodities and raw materials through a Dow subsidiary and pays a commission to that Dow subsidiary based on the volume and type of commodities and raw materials purchased. The commission expense is included in “Sundry income (expense) — net” in the consolidated statements of income. Purchases from that Dow subsidiary were approximately $847 million in the third quarter of 2006 ($550 million in the third quarter of 2005) and $2,377$693 million in the first nine monthsquarter of 2006 ($1,7252007 and $805 million in the first nine monthsquarter of 2005).

13




2006.

The Corporation has a master services agreement with Dow whereby Dow provides services, including, but not limited to, accounting, legal, treasury (investments, cash management, risk management, insurance), procurement, human resources, environmental, health and safety, and business management for UCC. Under the master services agreement with Dow, for general administrative and overhead type services that Dow routinely allocates to various businesses, UCC is charged the cost of those services based on the Corporation’s and Dow’s relative manufacturing conversion costs. This arrangement results in a quarterly charge of approximately $5 million (included in “Sundry income (expense) — net”).

For services that Dow routinely charges based on effort, UCC is charged the cost of such services on a fully absorbed basis, which includes direct and indirect costs. Additionally, certain Dow employees are contracted to UCC and Dow is reimbursed for all direct employment costs of such employees. Management believes the method used for determining expenses charged by Dow is reasonable. Dow provides these services by leveraging its centralized functional service centers to provide services at a cost that management believes provides an advantage to the Corporation.

The monitoring and execution of risk management policies related to interest rate and foreign currency risks, which are based on Dow’s risk management philosophy, are provided as a service to UCC.

As part of Dow’s cash management process, UCC is a party to revolving loans with Dow that have LIBOR-based interest rates with varying maturities. At September 30, 2006,March 31, 2007, the Corporation had a note receivable of $2,226 million$2.8 billion from Dow under a revolving loan agreement. The Corporation may draw from this note receivable in support of its daily working capital requirements and, as such, the net effect of cash inflows and outflows under this revolving loan agreement is presented in the consolidated statements of cash flows as an operating activity.

The Corporation also has a separate revolving credit agreement with Dow that allows the Corporation to borrow or obtain credit enhancements up to an aggregate of $1 billion that matures December 30, 2007 pursuant to an amendment effective as of September 30, 2006; however, Dow may demand repayment with a 30-day written notice to the Corporation, subject to certain restrictions. A related collateral agreement provides for the replacement of certain existing pledged assets, primarily equity interests in various subsidiaries and joint ventures, with cash collateral. At September 30, 2006, $815March 31, 2007, $809 million was available under the revolving credit agreement. The cash collateral was reported as “Noncurrent receivable from related company” in the consolidated balance sheets.

The losses and additional costs incurred by the Corporation in 2005 due to hurricane Katrina were covered by the Corporation’s insurance program. The Corporation has an insurance receivable for losses incurred of $105 million at September 30, 2006March 31, 2007 from its insurer (an affiliate of Dow). Additionally, the Corporation has insurance coverage for lost sales and margins caused by hurricane Katrina. No amount of recovery for lost sales and margins hashad been recognized through September 30, 2006,at March 31, 2007, and will only be recognized when the amount of recovery is realized through agreement amongstamong the insurers.

The Corporation recorded equity earnings of approximately $10 million from Dow Canada Holding LP (“DCHLP”) for the first two months of 2006 which increased the investment balance to $10 million. On March 1, 2006, the Corporation transferred its 11.2 percent partnership interest in DCHLP to a newly formed corporation, GWN Holding, Inc. (“GWN”), in exchange for 11.2 percent of GWN’s common stock. The Corporation accounts for its 11.2 percent ownership interest in GWN using the cost method.

In accordance with the Amended and Restated Tax Sharing Agreement between the Corporation and Dow, the Corporation made a payment of $84 million to Dow in September 2006 to cover the Corporation’s estimated federal tax liability for the third quarter of 2006 ($268 million for the first nine months of 2006).

NOTE H     RESTRUCTURING

In the third quarter of 2006, the Corporation recorded restructuring charges totaling $13 million resulting from decisions made by management in the third quarter to improve the competitiveness of its global operations. The decision resulted in the write-off of the net book value of three manufacturing facilities totaling $10 million (the largest of which was $8 million associated with the shutdown of the peroxymeric chemicals production facility in St. Charles, Louisiana, in October 2006), and the write-off of the net book value of fixed assets related to the dissolution of a consolidated joint venture in China (ceasing operations in October 2006) totaling $3 million. The charges are shown as “Restructuring charges” in the consolidated statements of income.

1412




Union Carbide Corporation and Subsidiaries

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Pursuant to General Instruction H of Form 10-Q “Omission of Information by Certain Wholly-Owned Subsidiaries,” this section includes only management’s narrative analysis of the results of operations for the three- and nine-month periodsthree-month period ended September 30, 2006,March 31, 2007, the most recent periods,period, compared with the three- and nine-month periodsthree-month period ended September 30, 2005,March 31, 2006, the corresponding periodsperiod in the preceding fiscal year.

References below to “Dow” refer to The Dow Chemical Company and its consolidated subsidiaries, except as the context otherwise indicates.

The Corporation’s business activities comprise components of Dow’s global operations rather than stand-alone operations. Dow conducts its worldwide operations through global businesses. Because there are no separable reportable business segments for UCC under Statement of Financial Accounting Standards No. 131, “Disclosures about Segments of an Enterprise and Related Information,” and no detailed business information is provided to a chief operating decision maker regarding the Corporation’s stand-alone operations, the Corporation’s results are reported as a single operating segment.

DISCLOSURE REGARDING FORWARD-LOOKING INFORMATION

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements made by or on behalf of Union Carbide Corporation (the “Corporation” or “UCC”). This section covers the current performance and outlook of the Corporation. The forward-looking statements contained in this section and in other parts of this document involve risks and uncertainties that may affect the Corporation’s operations, markets, products, services, prices and other factors as more fully discussed elsewhere and in filings with the U.S. Securities and Exchange Commission (SEC). These risks and uncertainties include, but are not limited to, economic, competitive, legal, governmental and technological factors. Accordingly, there is no assurance that the Corporation’s expectations will be realized. The Corporation assumes no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.

RESULTS OF OPERATIONS

Total net sales for the thirdfirst quarter of 2007 were $1,726 million compared with $2,053 million for the first quarter of 2006, a decrease of 16 percent. Total net sales for the first quarter of last year included significant lump sum technology licensing revenue. Technology licensing revenue varies from period to period due to the nature of the business.

Net sales to related companies for the first quarter of 2007 were $1,900$1,673 million compared with $1,465$1,735 million for the thirdfirst quarter of 2005, an increase2006, a decrease of 304 percent. Selling prices to Dow are based on market prices for the related products. Average selling prices for most products were higher in the thirdfirst quarter of 2007 compared with the first quarter of 2006, led by polyethylene, polypropylene and ethylene glycol (“EG”), reflecting significantly higher raw material costs. Overallvinyl acetate monomer (“VAM”) and oxo products. Sales volume for the third quarter of 2006 was up solidly comparedmixed with the low levels of the third quarter last year, which had been negatively impacted by disruptions in production and distribution caused by two hurricanes affecting the U.S. Gulf Coast. Total net sales were $5,729 million for the first nine months of 2006 compared with $4,733 million for the first nine months of 2005, an increase of 21 percent. On a year-to-date basis, total net sales were favorably impacted by lump sum technology licensing revenue earnedoverall volume down in the first quarter of 2006. Average selling prices for most products were higher for the first nine months of 20062007 compared with the same period last year, ledfirst quarter of 2006. Volume growth for several products (led by polyethyleneVAM, oxo products, and polypropylene. On a year-to-date basis, overallpolyethylene) was more than offset by declines in the Corporation’s other products, principally EG. The decline in EG volume showed solid improvement with gainswas related to scheduled plant turnarounds in polyethylene, EG and ethylene oxide.the first quarter of 2007.

Cost of sales fordecreased 2 percent from $1,636 million in the thirdfirst quarter of 2006 increased 31 percent compared withto $1,598 million in the thirdfirst quarter of 2005, and cost of sales for the first nine months of 2006 increased 20 percent compared with the same period last year,2007 principally due to higher raw material costs.

Restructuring charges of $13 million included the write-off of the net book value of three manufacturing facilities totaling $10 million (the largest of which was $8 million associated with the shutdown of the peroxymeric chemicals production facility in St. Charles, Louisiana, in October 2006)lower feedstock and the write-off of the net book value of fixed assets related to the dissolution of a consolidated joint venture in China (ceasing operations in October 2006) totaling $3 million.energy costs and lower sales volume.

Equity in earnings of nonconsolidated affiliates was $144increased $63 million in the thirdfirst quarter of 20062007 compared with $105 million in the same quarter last year. Improvedyear, led by a substantial improvement in earnings fromreported by the OPTIMAL Group (“OPTIMAL”), as well as higher reported earnings from EQUATE Petrochemical Co.Company K.S.C. (“EQUATE”) and Univation Technologies, LLC more than offset the absence of equity earningsLLC. Results from UOP LLC (which the Corporation exitedEQUATE and OPTIMAL were lower in the fourthfirst quarter of 2005). Year to date, equity in earnings of nonconsolidated affiliates was $288 million, down from $356 million last year principally2006 due to planned maintenance turnarounds at the absence of equity earnings from UOP LLC.joint ventures.

Sundry income (expense)expense — net includes a variety of income and expense items such as the gain or loss on foreign currency exchange, dividends from investments, commissions, charges for management services provided by Dow, and gains and losses on sales of investments and assets. Sundry income (expense)expense — net for the thirdfirst quarter of 20062007 was net expense of $16$10 million compared with net expense of $2 million for the third quarter last year. Net sundry expense for the third quarter

15




Results of Operations - Continued

of 2005 included a gain of $9 million associated with the sale of investments. Year to date, Sundry income (expense) — net was net expense of $60 million compared with net income of $51$21 million for the first nine monthsquarter of last year. Net sundry incomeSundry expense for the first nine monthsquarter of 2005 benefited from2007 was favorably impacted by a $70 million pretax gain on the salehigher level of a portion of the Corporation’s interest in EQUATE and dividend income of $29 million from Dow Chemical Canada Inc.and lower commission expense.

Interest income was $34 million in the third quarter of 2006 compared with $6 million in the third quarter of 2005. Year to date, interest income was $92 million, up from $16$37 million in the first nine monthsquarter of 20052007 compared with $23 million in the first quarter of 2006, due to higher interest rates and a significantly higheran increased level of interest-bearinginterest bearing assets.

Interest expense and amortization of debt discount was $14increased $2 million in the thirdfirst quarter of 20062007 compared with $15 million in the thirdfirst quarter of 2005. Year to date, interest expense and amortization of debt discount was $40 million, down from $57 million for the first nine months of 2005, due to the reduction of long-term debt which resulted from the early extinguishment of approximately $436 million of debt, primarily in the second quarter of 2005.2006.

The effective tax rate fluctuates based on, among other factors, where income is earned, the level of after-tax income from joint ventures, and the level of income relative to tax credits available. The effective tax rate for the thirdfirst quarter of 20062007 was 24.021.5 percent compared with 14.434.9 percent for the same quarter last year. The effective tax rate for the third quarter of 2005 reflects the favorable impact of $21 million for adjustments resulting from the finalization of calculations following the closure of prior tax years. Year to date, the effective tax rate was 31.5 percent versus 25.9 percent last year. The effective tax rate for the first nine months of 2006 was higher than the same period last year principally due to lower earnings from the Corporation’s joint ventures. Since most of the earnings from nonconsolidated


affiliates are taxed at the joint venture level, the impact of lowerhigher equity earnings increaseddecreased the Corporation’s overall effective tax rate. In addition, the year-to-date effective tax rate for 2005 reflects the favorable impact of $29 million of dividend income from Dow Canada in the second quarter of 2005, which was based on previously taxed income.

The Corporation reported net income of $218$186 million for the thirdfirst quarter of 2006,2007, compared with $184$283 million for the thirdfirst quarter of 2005. The2006. While the results for the thirdfirst quarter of 20062007 were favorably impacted by an increase in gross margin and higher equity earnings. Net income for the first nine months of 2006 of $656 millionearnings, this improvement was essentially unchanged from $654 million for the first nine months of 2005.more than offset by a significant decline in technology licensing revenue.

OTHER MATTERS

Accounting Changes

See Note B to the Consolidated Financial Statements for a discussion of accounting changes and recently issuedrecent accounting pronouncements.

Critical Accounting Policies

The preparation of financial statements and related disclosures in conformity with GAAPaccounting principles generally accepted in the United States of America (“GAAP”) requires management to make judgments, assumptions and estimates that affect the amounts reported in the Consolidated Financial Statements and accompanying notes. Note A to the Consolidated Financial Statements in the Corporation’s Annual Report on Form 10-K for the year ended December 31, 20052006 (“20052006 10-K”) describes the significant accounting policies and methods used in the preparation of the Consolidated Financial Statements. The Corporation’s critical accounting policies that are impacted by judgments, assumptions and estimates are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Corporation’s 20052006 10-K. Since December 31, 2005,2006, there have been no material changes in the Corporation’s critical accounting policies.

Asbestos-Related Matters

Introduction

The Corporation is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past three decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that UCC sold in the past, alleged exposure to asbestos-containing products located on UCC’s premises, and UCC’s responsibility for asbestos suits filed against a former subsidiary, Amchem Products, Inc. (“Amchem”). In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to the Corporation’s products.

Influenced by the bankruptcy filings of numerous defendants in asbestos-related litigation and the prospects of various forms of state and national legislative reform, the rate at which plaintiffs filed asbestos-related suits against various companies, including the Corporation and Amchem, increased in 2001, 2002 and the first half of 2003. Since then, the rate of filing has significantly abated. The Corporation expects more asbestos-related suits to be filed against it and Amchem in the future, and will aggressively defend or reasonably resolve, as appropriate, both pending and future claims.

16




The table below provides information regarding asbestos-related claims filed against the Corporation and Amchem:

 

2006

 

2005

 

 

2007

 

2006

 

Claims unresolved at January 1

 

146,325

 

203,416

 

 

111,887

 

146,325

 

Claims filed

 

12,388

 

27,715

 

 

3,085

 

5,402

 

Claims settled, dismissed or otherwise resolved

 

(45,006

)

(51,928

)

 

(2,225

)

(7,921

)

Claims unresolved at September 30

 

113,707

 

179,203

 

Claims unresolved at March 31

 

112,747

 

143,806

 

Claimants with claims against both UCC and Amchem

 

39,432

 

61,524

 

 

38,901

 

47,779

 

Individual claimants at September 30

 

74,275

 

117,679

 

Individual claimants at March 31

 

73,846

 

96,027

 

 

Plaintiffs’ lawyers often sue dozens or even hundreds of defendants in individual lawsuits on behalf of hundreds or even thousands of claimants. As a result, the damages alleged are not expressly identified as to UCC, Amchem or any other particular defendant, even when specific damages are alleged with respect to a specific disease or injury. In fact, there are no personal injury cases in which only the Corporation and/or Amchem are the sole named defendants. For these reasons and based upon the Corporation’s litigation and settlement experience, the Corporation does not consider the damages alleged against it and Amchem to be a meaningful factor in its determination of any potential asbestos liability.

Estimating the Liability

Based on a study completed by Analysis, Research & Planning Corporation (“ARPC”) in January 2003, the Corporation increased its December 31, 2002 asbestos-related liability for pending and future claims for the 15-year period ending in


Asbestos-Related Matters—Continued

2017 to $2.2 billion, excluding future defense and processing costs. At each balance sheet date,Since then, the Corporation compareshas compared current asbestos claim and resolution activity to the assumptions inresults of the most recent ARPC study at each balance sheet date to determine whether the accrual continues to be appropriate.

In November 2004, the Corporation requested ARPC to review the Corporation’s historical asbestos claim and resolution activity and determine the appropriateness of updating its January 2003 study. In January 2005, ARPC provided the Corporation with a report summarizing the results of its study. At December 31, 2004, the recorded asbestos-related liability for pending and future claims was $1.6 billion. Based on the low end of the range in the January 2005 study, the recorded asbestos-related liability for pending and future claims at December 31, 2004 would be sufficient to resolve asbestos-related claims against UCC and Amchem into 2019. As in its January 2003 study, ARPC provideddid provide estimates for a longer period of time in its January 2005 study, but also reaffirmed its prior advice that forecasts for shorter periods of time are more accurate than those for longer periods of time. Based on ARPC’s studies, the Corporation’s asbestos litigation experience, and the uncertainties surrounding asbestos litigation and legislative reform efforts, management determined that no change to the accrual was required at December 31, 2004.

In November 2005, the Corporation requested ARPC to review the Corporation’s 2005 asbestos claim and resolution activity and determine the appropriateness of updating theits January 2005 study. In response to that request, ARPC reviewed and analyzed data through October 31, 2005. In January 2006, ARPC stated that an update of theits study would not provide a more likely estimate of future events than the estimate reflected in its study of the previous year and, therefore, the estimate in that study remained applicable.

Based on the Corporation’s own review of the asbestos claim and resolution activity and ARPC’s response, the Corporation determined that no change to the accrual was required atrequired. At December 31, 2005. The2005, the recorded asbestos-related liability for pending and future claims was $1.5 billion.

In November 2006, the Corporation requested ARPC to review the Corporation’s historical asbestos claim and resolution activity and determine the appropriateness of updating its January 2005 study. In response to that request, ARPC reviewed and analyzed data through October 31, 2006 and concluded that the experience from 2004 through 2006 was sufficient for the purpose of forecasting future filings and values of asbestos claims filed against UCC and Amchem, and could be used in place of previous assumptions to update its January 2005 study. The resulting study, completed by ARPC in December 2006, stated that the undiscounted cost of resolving pending and future asbestos-related claims against UCC and Amchem, excluding future defense and processing costs, through 2021 was estimated to be between approximately $1.2 billion and $1.5 billion. As in its January 2005 study, ARPC provided estimates for a longer period of time in its December 2006 study, but also reaffirmed its prior advice that forecasts for shorter periods of time are more accurate than those for longer periods of time.

Based on ARPC’s December 2006 study and the Corporation’s own review of the asbestos claim and resolution activity, the Corporation decreased its asbestos-related liability for pending and future claims to $1.2 billion at December 31, 2005. Approximately 392006 which covers the 15-year period ending in 2021 (excluding future defense and processing costs). The reduction was $177 million and was shown as “Asbestos-related credit” in the consolidated statements of income for 2006. At December 31, 2006, approximately 25 percent of the recorded liability related to pending claims and approximately 6175 percent related to future claims.

Based on the Corporation’s review of 20062007 activity, the Corporation determined that no changeadjustment to the accrual was required at September 30, 2006.March 31, 2007. The asbestos-related liability for pending and future claims was $1.4$1.2 billion at September 30, 2006.March 31, 2007. Approximately 3528 percent of the recorded liability related to pending claims and approximately 6572 percent related to future claims.

Defense and Resolution Costs

The following table provides information regarding defense and resolution costs related to asbestos-related claims filed against the Corporation and Amchem:

Defense and Resolution Costs

 

Nine Months Ended

 

Aggregate Costs

 

 

Three Months Ended

 

Aggregate Costs

 

In millions

 

Sept. 30,
2006

 

Sept. 30,
2005

 

to Date as of
Sept. 30, 2006

 

 

March 31,
2007

 

March 31,
2006

 

to Date as of
March 31, 2007

 

Defense costs

 

$

45

 

$

55

 

$

464

 

 

$

17

 

$

14

 

$

498

 

Resolution costs

 

$

95

 

$

122

 

$

1,160

 

 

$

16

 

$

27

 

$

1,198

 

 

17




Asbestos-Related Matters — Continued

The average resolution payment per asbestos claimant and the rate of new claim filings has fluctuated both up and down since the beginning of 2001. Union Carbide’s management expects such fluctuations to continue in the future based upon a number of factors, including the number and type of claims settled in a particular period, the jurisdictions in which such claims arose, and the extent to which any proposed legislative reform related to asbestos litigation is being considered.

The Corporation expenses defense costs as incurred. The pretax impact for defense and resolution costs, net of insurance, was $17 million in the first quarter of 2007 and $14 million in the first quarter of 2006, and was reflected in “Cost of sales.”


Insurance Receivables

At December 31, 2002, the Corporation increased the receivable for insurance recoveries related to its asbestos liability to $1.35 billion, substantially exhausting its asbestos product liability coverage. The insurance receivable related to the asbestos liability was determined after a thorough review of applicable insurance policies and the 1985 Wellington Agreement, to which the Corporation and many of its liability insurers are signatory parties, as well as other insurance settlements, with due consideration given to applicable deductibles, retentions and policy limits, and taking into account the solvency and historical payment experience of various insurance carriers. The Wellington Agreement and other agreements with insurers are designed to facilitate an orderly resolution and collection of the Corporation’s insurance policies and to resolve issues that the insurance carriers may raise.

The Corporation’s receivable for insurance recoveries related to its asbestos liability was $478 million at September 30, 2006 and $535 million at December 31, 2005. At September 30, 2006, $477 million ($398 million at December 31, 2005) of the receivable for insurance recoveries was related to insurers that are not signatories to the Wellington Agreement and/or do not otherwise have agreements in place regarding their asbestos-related insurance coverage.

In addition, the Corporation had receivables for defense and resolution costs submitted to insurance carriers for reimbursement as follows:

Receivables for Costs Submitted to Insurance Carriers

In millions

 

September 30,
2006

 

December 31,
2005

 

Receivables for defense costs

 

$

9

 

$

73

 

Receivables for resolution costs

 

342

 

327

 

Total

 

$

351

 

$

400

 

The Corporation expenses defense costs as incurred. The pretax impact for defense and resolution costs, net of insurance, was $1 million in the third quarter of 2006 ($24 million in the third quarter of 2005), and $29 million in the first nine months of 2006 ($56 million in the first nine months of 2005), and was reflected in “Cost of sales.”

In September 2003, the Corporation filed a comprehensive insurance coverage case, now proceeding in the Supreme Court of the State of New York, County of New York, seeking to confirm its rights to insurance for various asbestos claims and to facilitate an orderly and timely collection of insurance proceeds. Although the Corporation already has settlements in place concerning coverage for asbestos claims with many of its insurers, including those covered by the 1985 Wellington Agreement, thisThis lawsuit was filed against insurers that are not signatories to the Wellington Agreement and/or do not otherwise have agreements in place with the Corporation regarding their asbestos-related insurance coverage, in order to facilitate an orderly resolution and collection of such insurance policies and to resolve issues that the insurance carriers may raise. The insurance carriers are contesting this litigation. ThroughAlthough the thirdlawsuit is continuing, through the end of the first quarter of 2006,2007, the Corporation had reached settlements with several of the carriers involved in this litigation.

The Corporation’s receivable for insurance recoveries related to its asbestos liability was $484 million at March 31, 2007 and $495 million at December 31, 2006. At March 31, 2007 and December 31, 2006, all of the receivable for insurance recoveries was related to insurers that are not signatories to the Wellington Agreement and/or do not otherwise have agreements in place regarding their asbestos-related insurance coverage.

In addition to the receivable for insurance recoveries related to its asbestos liability, the Corporation had receivables for defense and resolution costs submitted to insurance carriers for reimbursement as follows:

Receivables for Costs Submitted to Insurance Carriers

In millions

 

March 31,
2007

 

Dec 31,
2006

 

Receivables for defense costs

 

$

35

 

$

34

 

Receivables for resolution costs

 

265

 

266

 

Total

 

$

300

 

$

300

 

After a further review of its insurance policies, with due consideration given to applicable deductibles, retentions and policy limits, after taking into account the solvency and historical payment experience of various insurance carriers; existing insurance settlements; and the advice of outside counsel with respect to the applicable insurance coverage law relating to the terms and conditions of its insurance policies, the Corporation continues to believe that its recorded receivable for insurance recoveries from all insurance carriers is probable of collection.

Summary

The amounts recorded for the asbestos-related liability and related insurance receivable described above were based upon current, known facts. However, future events, such as the number of new claims to be filed and/or received each year, the average cost of disposing of each such claim, coverage issues among insurers, and the continuing solvency of various insurance companies, as well as the numerous uncertainties surrounding asbestos litigation in the United States, could cause the actual costs and insurance recoveries to be higher or lower than those projected or those recorded.

Because of the uncertainties described above, management cannot estimate the full range of the cost of resolving pending and future asbestos-related claims facing the Corporation and Amchem. Management believes that it is reasonably possible that the cost of disposing of the Corporation’s asbestos-related claims, including future defense costs, could have a material adverse impact on the results of operations and cash flows for a particular period and on the consolidated financial position of the Corporation.

18




ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Omitted pursuant to General Instruction H of Form 10-Q.

ITEM 4.  CONTROLS AND PROCEDURES.

As of the end of the period covered by this Quarterly Report on Form 10-Q, the Corporation carried out an evaluation, under the supervision and with the participation of the Corporation’s Disclosure Committee and the Corporation’s management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Corporation’s disclosure controls and procedures pursuant to Exchange Act Rule 15d-15(b); and whether any change has occurred in the Corporation’s internal control over financial reporting pursuant to Exchange Act Rule 15d-15(d). Based upon that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Corporation’s disclosure controls and procedures are effective and that no change in the Corporation’s internal control over financial reporting occurred during the Corporation’s most recent fiscal quarter that materially affected, or is reasonably likely to materially affect, the Corporation’s internal control over financial reporting.

PART II — OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS.

No material developments in asbestos-related matters occurred during the thirdfirst quarter of 2006.2007. For a summary of the history and current status of asbestos-related matters, see Management’s Discussion and Analysis of Financial Condition and Results of Operations, Asbestos-Related Matters; and Note E to the Consolidated Financial Statements.

ITEM 1A.  RISK FACTORS.

There were no material changes in the Corporation’s risk factors in the thirdfirst quarter of 2006.2007.

ITEM 6.  EXHIBITS.

See the Exhibit Index on page 2119 of this Quarterly Report on Form 10-Q for exhibits filed with this report.

1917




Union Carbide Corporation and Subsidiaries

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

UNION CARBIDE CORPORATION

 

 

Registrant

 

 

 

 

 

 

 

 

 

Date: October 31, 2006May 1, 2007

 

 

 

 

 

 

 

 

 

 

 

 

By:

/s/ WILLIAM H. WEIDEMAN

 

 

 

William H. Weideman

 

 

 

Vice President and Controller

 

 

 

The Dow Chemical Company

 

 

 

Authorized Representative of

 

 

 

Union Carbide Corporation

 

 

 

 

 

 

 

 

 

 

By:

/s/ EDWARD W. RICH

 

 

 

Edward W. Rich

 

 

 

Vice President, Treasurer and

 

 

 

Chief Financial Officer

 

20





Union Carbide Corporation and Subsidiaries

Exhibit Index

 

EXHIBIT NO.

DESCRIPTION

 

 

10.5.4

Fourth Amendment to the Amended and Restated Revolving Credit Agreement, dated as of September 30, 2006, among the Corporation, The Dow Chemical Company and certain Subsidiary Guarantors.DESCRIPTION

 

 

 

23

 

Analysis, Research & Planning Corporation’s Consent.

 

 

 

31.1

 

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

31.2

 

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

32.1

 

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

32.2

 

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

2119